SPRY2 and gastric adenocarcinoma: Moreover, SPRY2 low-expression could indicate advanced T stage and positive lymphatic invasion (P = 0.002 and 0.001, respectively), suggesting the suppressive role of SPRY2 in gastric adenocarcinoma growth and invasion.